We are live on
!
Find out more
Glenview Capital Management Portfolio holdings
AUM
$5.49B
Turnover
46.55%
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.41%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.49B
AUM Growth
+$1.51B
(+38%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
60.68%
Holding
58
New
14
Increased
15
Reduced
15
Closed
13
Avg Time Held Equity + Options
1.7
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
1.2
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
1.8
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$240M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$181M |
| 3 |
Danaher
DHR
|
+$180M |
| 4 |
Global Payments
GPN
|
+$175M |
| 5 |
Meta Platforms (Facebook)
META
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$301M |
| 2 |
Advanced Micro Devices
AMD
|
+$144M |
| 3 |
DXC Technology
DXC
|
+$112M |
| 4 |
ZoomInfo Technologies
GTM
|
+$95.1M |
| 5 |
Centene
CNC
|
+$71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.86% |
| 2 | Industrials | 12.99% |
| 3 | Technology | 12.58% |
| 4 | Consumer Discretionary | 9.03% |
| 5 | Miscellaneous | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Lithia Motors
LAD
$6.41B
| – | – |
-127,605
| Closed | -$31.9M | – |
|
52
Myriad Genetics
MYGN
$391M
| – | – |
-5,411,978
| Closed | -$24.4M | – |
|
53
CALL
Invesco QQQ Trust
QQQ
$474B
| – | – |
-328,200
| Closed | -$189M | – |
|
54
Surgery Partners
SGRY
$1.91B
| – | – |
-1,800,000
| Closed | -$21.5M | – |
|
55
US Foods
USFD
$21.9B
| – | – |
-384,007
| Closed | -$35.4M | – |
|
56
Zillow
Z
$6.89B
| – | – |
-789,670
| Closed | -$32.7M | – |
|
|
57
ZoomInfo Technologies
GTM
$1.11B
| – | – |
-15,905,242
| Closed | -$95.1M | – |
|
58
Lionsgate Studios
LION
$3.15B
| – | – |
-2,778,781
| Closed | -$26.6M | – |
|
Similar funds
MC
SCM
Glenview Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Glenview Capital Management held 58 positions worth $5.49B, up 38% from $3.98B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Glenview Capital Management deployed $309M of net new capital in Q2 2026, opening 14 new positions and adding to 15 existing holdings. Its largest new stake was Agilent Technologies: 1,969,541 shares worth $262M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was CVS Health, an estimated $301M trimmed.
- Glenview Capital Management's largest Q2 2026 buy was Agilent Technologies: 1,969,541 shares worth $262M.
- Glenview Capital Management added most to Thermo Fisher Scientific in Q2 2026, an estimated $181M increase.
- Glenview Capital Management's biggest Q2 2026 reduction was CVS Health, cutting an estimated $301M.
- Glenview Capital Management fully exited DXC Technology in Q2 2026, selling an estimated $112M.
- Glenview Capital Management's ten largest holdings make up 61% of its $5.49B portfolio in Q2 2026.
- Glenview Capital Management opened 14 new positions and closed 13 in Q2 2026.
- Glenview Capital Management's portfolio value rose 38% quarter-over-quarter to $5.49B.
Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.